Leadership

Management

Ronald J. Zenk

President and CEO

Mr. Zenk is the the President, CEO, member of the Board of Directors and Founder of Humanetics Corporation.

John C. Dykstra

Chief Operating Officer

Mr. Dykstra has served as Chief Operating Officer of Humanetics since 1998 and is a member of the Board of Directors.

Mark Payne

Chief Financial Officer

Mr. Payne serves as Chief Financial Officer for Humanetics.

Michael D. Kaytor, Ph.D.

Vice President of Research and Development

Dr. Kaytor joined Humanetics in 2012 and serves as the Vice President of Research and Development.

Board of Directors

Timothy E. Morris

Director

Mr. Morris joined the Board in 2021.

James R. Behnke, Ph.D.

Director

Dr. Behnke has served as a member of the Board since 1992.

Karen L. Smith, M.D., Ph.D.

Director

Dr. Smith joined the Board in 2021.

Ronald J. Zenk

President and CEO

Mr. Zenk has served as a member of the Board since 1988.

John C. Dykstra

Chief Operating Officer

Mr. Dykstra has served as a member of the Board since 1999.

Admiral Matthew L. Nathan, M.D.

Director

Admiral Nathan has served as a member of the Board since 2020.

Medical Advisors

Zeljko Vujaskovic, MD, Ph.D.

Director of Division of Translational Radiation Sciences, University of Maryland

Dr. Vujaskovic specialized in research and clinical practice in the area of radiation oncology and radiation injury.

Robert C. Miller, MD

Professor of Radiation Oncology, University of Maryland School of Medicine

Dr. Miller is a practicing radiation oncologist within the University of Maryland School of Medicine and is the Medical Director of the Maryland Proton Treatment Center.

Colin G. Chinn, MD, MHS, FACP

Rear Admiral, U.S. Navy (Ret.)

Dr. Chinn was the 14th Staff Surgeon and senior advisor to the Chairman of the Joint Chiefs.

Scientific Advisors

Isabel L. Jackson, Ph.D.

Assistant Professor of Radiation Oncology, University of Maryland

Dr. Jackson's area of expertise is focused on understanding the mechanisms underlying radiation effects in tissue.

Michael R. Landauer, Ph.D.

Scientist Emeritus, Armed Forces Radiobiology Research Institute

Dr. Landauer is a radiation countermeasure consultant.

Ronald G. Manning, Ph.D.

Former Chief, Chemical, Radiological and Nuclear Medical Countermeasures, BARDA

Dr. Manning is a distinguished scientists that has expertise in development of Medical Countermeasures.